Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation... see more

OTCPK:GBGPF - Post Discussion

GB Group Ord Shs > Why I bought back in today
View:
Post by Valuewalk on Nov 27, 2017 8:26pm

Why I bought back in today

I agree CMED management is not great, and that's why they are in a hostile takeover situation with a more savvy competitor. People can get revenge for the past 10 years of mismanagement by selling if they want.

Im surprised some people are buying in to the argument that ACB's shares are overvalued the narrative being pushed by the SAME CMED management! 

ACB traded 70 MILLION shares TODAY in Canada. That is pretty good price discovery. 

At CMED's current price you get ACB at an 18% DISCOUNT.

ACB is up 30% since the merger was announced, CMED is only up 33%! 

Even if the deal falls through (doubtful) CMED is trading in line with ACB and the sector as if the offer never happened. Yet on top of that we have the highly likely buyout at $24. Whats even more, with ACB's rise, there is a very small chance of getting less than $24 of ACB shares. BUT, the best part is, if the sector keeps rising, ACB will be compelled to SWEETEN the offer because it will no longer be a significant premium to where the MJ stocks have been trading as a group. Plus at the end of the day we become part of something bigger with excellent management. 

Do you really think the institutions in CMED dont know what they are doing? Very good risk/reward in CMED at these prices, in my opinion.
Comment by true377 on Nov 27, 2017 9:24pm
but how do you know what todays price will be worth in March and $3.60 on 1000 shares is $20260 $24000 = $3740 gain over 5 months = $748 a month when the sector is ripping
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities